These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35442178)

  • 1. Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine.
    Landis RK; Levin JS; Saloner B; Gordon AJ; Dick AW; Sherry TB; Leslie DL; Sorbero M; Stein BD
    Subst Abus; 2022 Dec; 43(1):1057-1071. PubMed ID: 35442178
    [No Abstract]   [Full Text] [Related]  

  • 2. Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies.
    Landis RK; Opper I; Saloner B; Gordon AJ; Leslie DL; Sorbero M; Stein BD
    Drug Alcohol Depend; 2022 Dec; 241():109669. PubMed ID: 36332589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.
    Xu KY; Schiff DM; Jones HE; Martin CE; Kelly JC; Bierut LJ; Carter EB; Grucza RA
    J Gen Intern Med; 2023 Dec; 38(16):3499-3508. PubMed ID: 37436568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
    Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
    J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
    ; Donohue JM; Jarlenski MP; Kim JY; Tang L; Ahrens K; Allen L; Austin A; Barnes AJ; Burns M; Chang CH; Clark S; Cole E; Crane D; Cunningham P; Idala D; Junker S; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Pauly N; Sheets L; Talbert J; Zivin K; Gordon AJ; Kennedy S
    JAMA; 2021 Jul; 326(2):154-164. PubMed ID: 34255008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.
    Stein BD; Dick AW; Sorbero M; Gordon AJ; Burns RM; Leslie DL; Pacula RL
    Subst Abus; 2018; 39(4):419-425. PubMed ID: 29932847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in buprenorphine treatment quality across physician provider specialties.
    Levin JS; Landis RK; Sorbero M; Dick AW; Saloner B; Stein BD
    Drug Alcohol Depend; 2022 Aug; 237():109510. PubMed ID: 35753279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
    Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
    Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociodemographic and prescribing characteristics that impact long-term retention in buprenorphine treatment for opioid use disorder among a statewide population.
    Hallowell BD; Chambers LC; Samuels EA; Bratberg J; McDonald J; Nitenson A; Onyejekwe C; Beaudoin FL
    Drug Alcohol Depend; 2022 Dec; 241():109680. PubMed ID: 36335834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Risk Prescribing to Medicaid Enrollees Receiving Opioid Analgesics: Individual- and County-Level Factors.
    Heins SE; Sorbero MJ; Jones CM; Dick AW; Stein BD
    Subst Use Misuse; 2018 Aug; 53(10):1591-1601. PubMed ID: 29303393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid analgesic and benzodiazepine prescribing among Medicaid-enrollees with opioid use disorders: The influence of provider communities.
    Stein BD; Mendelsohn J; Gordon AJ; Dick AW; Burns RM; Sorbero M; Shih RA; Liccardo Pacula R
    J Addict Dis; 2017; 36(1):14-22. PubMed ID: 27449904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.
    Peterson L; Murugesan M; Nocon R; Hoang H; Bolton J; Laiteerapong N; Pollack H; Marsh J
    PLoS One; 2022; 17(10):e0276066. PubMed ID: 36256662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial‒Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid.
    Dunphy CC; Zhang K; Xu L; Guy GP
    Am J Prev Med; 2022 Nov; 63(5):717-725. PubMed ID: 35803789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program.
    Gordon AJ; Lo-Ciganic WH; Cochran G; Gellad WF; Cathers T; Kelley D; Donohue JM
    J Addict Med; 2015; 9(6):470-7. PubMed ID: 26517324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral buprenorphine utilization, concomitant benzodiazepines and opioid analgesics, and payment source: Trends from 2015 to 2019.
    Ijioma SC; Chilcoat HD; DeVeaugh-Geiss AM
    J Subst Use Addict Treat; 2023 Apr; 147():208980. PubMed ID: 36841074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder.
    Ellis MS; Xu KY; Tardelli VS; Fidalgo TM; Buttram ME; Grucza RA
    JAMA Psychiatry; 2023 Dec; 80(12):1269-1276. PubMed ID: 37672238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
    Wen H; Hockenberry JM; Pollack HA
    JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
    Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.